Skip to main content
Robert Harrington, MD, Cardiology, New York, NY, Stanford Health Care

RobertHarringtonMD

Cardiology New York, NY

Interventional Cardiology

Stephen and Suzanne Weiss Dean, Weill Cornell Medicine and Provost for Medical Affairs, Cornell University

Dr. Harrington is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Harrington's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1990 - 1993
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1986

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2023 - 2025
  • CA State Medical License
    CA State Medical License 2012 - 2025
  • NC State Medical License
    NC State Medical License 1993 - 2017
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Alirocumab and Cardiovascular Outcomes After Acute Coronary Syndrome  
    Vera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
  • Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...  
    Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
  • Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER Trial  
    Paolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect

Press Mentions

  • Heart Disease After COVID: What the Data Say
    Heart Disease After COVID: What the Data SayAugust 2nd, 2022
  • Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
    Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)August 2nd, 2022
  • CV Drugs Not Linked to Poor Outcomes in Patients at High Risk for COVID-19
    CV Drugs Not Linked to Poor Outcomes in Patients at High Risk for COVID-19August 9th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations